cloudfront
  • info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) | +1-214-736-7666 (US) | +1-740-994-0111 (US)
  • Sign In
  • Register

Report Detail



Pharma & Healthcare2018-2023 Global Brand Drugs Consumption Market Report

  • RnM2475686
  • |
  • 29 August, 2018
  • |
  • Global
  • |
  • 165 pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Table of Contents

2018-2023 Global Brand Drugs Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Brand Drugs Consumption 2013-2023
2.1.2 Brand Drugs Consumption CAGR by Region
2.2 Brand Drugs Segment by Type
2.2.1 Biopharmaceutical
2.2.2 Chemistry Medicine
2.3 Brand Drugs Consumption by Type
2.3.1 Global Brand Drugs Consumption Market Share by Type (2013-2018)
2.3.2 Global Brand Drugs Revenue and Market Share by Type (2013-2018)
2.3.3 Global Brand Drugs Sale Price by Type (2013-2018)
2.4 Brand Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Brand Drugs Consumption by Application
2.5.1 Global Brand Drugs Consumption Market Share by Application (2013-2018)
2.5.2 Global Brand Drugs Value and Market Share by Application (2013-2018)
2.5.3 Global Brand Drugs Sale Price by Application (2013-2018)

3 Global Brand Drugs by Players
3.1 Global Brand Drugs Sales Market Share by Players
3.1.1 Global Brand Drugs Sales by Players (2016-2018)
3.1.2 Global Brand Drugs Sales Market Share by Players (2016-2018)
3.2 Global Brand Drugs Revenue Market Share by Players
3.2.1 Global Brand Drugs Revenue by Players (2016-2018)
3.2.2 Global Brand Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Brand Drugs Sale Price by Players
3.4 Global Brand Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Brand Drugs Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Brand Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Brand Drugs by Regions
4.1 Brand Drugs by Regions
4.1.1 Global Brand Drugs Consumption by Regions
4.1.2 Global Brand Drugs Value by Regions
4.2 Americas Brand Drugs Consumption Growth
4.3 APAC Brand Drugs Consumption Growth
4.4 Europe Brand Drugs Consumption Growth
4.5 Middle East & Africa Brand Drugs Consumption Growth

5 Americas
5.1 Americas Brand Drugs Consumption by Countries
5.1.1 Americas Brand Drugs Consumption by Countries (2013-2018)
5.1.2 Americas Brand Drugs Value by Countries (2013-2018)
5.2 Americas Brand Drugs Consumption by Type
5.3 Americas Brand Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Brand Drugs Consumption by Countries
6.1.1 APAC Brand Drugs Consumption by Countries (2013-2018)
6.1.2 APAC Brand Drugs Value by Countries (2013-2018)
6.2 APAC Brand Drugs Consumption by Type
6.3 APAC Brand Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Brand Drugs by Countries
7.1.1 Europe Brand Drugs Consumption by Countries (2013-2018)
7.1.2 Europe Brand Drugs Value by Countries (2013-2018)
7.2 Europe Brand Drugs Consumption by Type
7.3 Europe Brand Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Brand Drugs by Countries
8.1.1 Middle East & Africa Brand Drugs Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Brand Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Brand Drugs Consumption by Type
8.3 Middle East & Africa Brand Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Brand Drugs Distributors
10.3 Brand Drugs Customer

11 Global Brand Drugs Market Forecast
11.1 Global Brand Drugs Consumption Forecast (2018-2023)
11.2 Global Brand Drugs Forecast by Regions
11.2.1 Global Brand Drugs Forecast by Regions (2018-2023)
11.2.2 Global Brand Drugs Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Brand Drugs Forecast by Type
11.8 Global Brand Drugs Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Details
12.1.2 Brand Drugs Product Offered
12.1.3 Pfizer Brand Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Pfizer News
12.2 Roche
12.2.1 Company Details
12.2.2 Brand Drugs Product Offered
12.2.3 Roche Brand Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Roche News
12.3 Sanofi
12.3.1 Company Details
12.3.2 Brand Drugs Product Offered
12.3.3 Sanofi Brand Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Sanofi News
12.4 Johnson & Johnson
12.4.1 Company Details
12.4.2 Brand Drugs Product Offered
12.4.3 Johnson & Johnson Brand Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Johnson & Johnson News
12.5 Merck & Co. (MSD)
12.5.1 Company Details
12.5.2 Brand Drugs Product Offered
12.5.3 Merck & Co. (MSD) Brand Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Merck & Co. (MSD) News
12.6 Novartis
12.6.1 Company Details
12.6.2 Brand Drugs Product Offered
12.6.3 Novartis Brand Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Novartis News
12.7 AbbVie
12.7.1 Company Details
12.7.2 Brand Drugs Product Offered
12.7.3 AbbVie Brand Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 AbbVie News
12.8 Gilead Sciences
12.8.1 Company Details
12.8.2 Brand Drugs Product Offered
12.8.3 Gilead Sciences Brand Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Gilead Sciences News
12.9 GlaxoSmithKline (GSK)
12.9.1 Company Details
12.9.2 Brand Drugs Product Offered
12.9.3 GlaxoSmithKline (GSK) Brand Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 GlaxoSmithKline (GSK) News
12.10 Amgen
12.10.1 Company Details
12.10.2 Brand Drugs Product Offered
12.10.3 Amgen Brand Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Amgen News
12.11 AstraZeneca
12.12 Bristol-Myers Squibb
12.13 Eli Lilly
12.14 Teva
12.15 Bayer
12.16 Novo Nordisk
12.17 Allergan
12.18 Shire
12.19 Boehringer Ingelheim
12.20 Takeda

13 Research Findings and Conclusion

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Brand Drugs market for 2018-2023.

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
Over the next five years, LPI(LP Information) projects that Brand Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Brand Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:
Biopharmaceutical
Chemistry Medicine
Segmentation by application:
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Shire
Boehringer Ingelheim
Takeda

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Brand Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Brand Drugs market by identifying its various subsegments.
Focuses on the key global Brand Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Brand Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Brand Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.




Summary:
Get latest Market Research Reports on Brand Drugs . Industry analysis & Market Report on Brand Drugs is a syndicated market report, published as 2018-2023 Global Brand Drugs Consumption Market Report. It is complete Research Study and Industry Analysis of Brand Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$4,660.00
$6,990.00
$9,320.00
3,129.19
4,693.79
6,258.38
4,288.13
6,432.20
8,576.26
564,512.40
846,768.60
1,129,024.80
309,020.44
463,530.67
618,040.89
Add To Cart Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report